Napo Pharmaceuticals, Inc.
Napo Pharmaceuticals, Inc.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Open-Label Pilot Study With Crofelemer in Patients With Short Bowel Syndrome | Digestive System Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, digestive system disorder, intestinal disorder, malabsorption syndrome, short bowel syndrome | Active, not recruiting | Early phase 1 | 2026-08-19 | NCT06326645 | |
| Ascending Doses of Crofelemer Powder for Oral Solution in Pediatric Microvillus Inclusion Disease (MVID) | Congenital Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Rare Diseases, microvillus inclusion disease | Active, not recruiting | Phase 2 / Phase 3 | 2026-06-09 | NCT06721871 |